Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Health . The role of Post-Doctoral Fellow reports to the Deputy Director, Implementation to Impact program, and will have one direct report. Some key skills required: A PhD in a related discipline, and/or
-
) A PhD in a related discipline, and/or relevant work experience. Experience in at least two of the following areas: engineering design, thermodynamics calculations, heat transfer, fluid flow, radiation
-
focused on understanding and countering harmful narratives and, mis/disinformation, and applying social network analysis. To be successful you will need: PhD in a relevant discipline such as computer
-
-lab.com/ ) • Focus: Structure/function of chromatin-associated complexes using cryo-EM and biochemical approaches • Requirements: PhD in structural biology/protein biochemistry; expertise in protein complex
-
ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak reactors. We are recruiting
-
, turbulence-chemistry interactions in flames ranging from fully premixed to stratified and non-premixed, auto-ignition of both gaseous and liquid fuels, spray atomisation, combustion safety in deflagrations
-
Assistant, you will play a crucial role in executing and supporting laboratory experiments, working closely with PhD students, postdocs, and senior researchers. Your responsibilities will include, but are not
-
strategies. Key skills required: A PhD in a related discipline, and/or relevant work experience. Proven commitment to proactively keeping up to date with discipline knowledge and developments. Demonstrated
-
combatting wildlife trafficking and environmental harm. To be successful you will need: PhD in a relevant discipline such as computer science, data science, digital forensics, cyber security or a related field
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural